- Home
- OBIO vs SLND Comparison
OBIO vs SLND Comparison
Compare OBIO & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- SLND
- Stock Information
- Founded
- OBIO 2017
- SLND 1900
- Country
- OBIO United States
- SLND United States
- Employees
- OBIO N/A
- SLND 2500
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- SLND Military/Government/Technical
- Sector
- OBIO Health Care
- SLND Industrials
- Exchange
- OBIO Nasdaq
- SLND Nasdaq
- Market Cap
- OBIO 198.2M
- SLND 172.1M
- IPO Year
- OBIO N/A
- SLND N/A
- Fundamental
- Price
- OBIO $4.72
- SLND $3.19
- Analyst Decision
- OBIO Strong Buy
- SLND Buy
- Analyst Count
- OBIO 4
- SLND 2
- Target Price
- OBIO $16.25
- SLND $5.50
- AVG Volume (30 Days)
- OBIO 50.3K
- SLND 23.6K
- Earning Date
- OBIO 03-26-2025
- SLND 03-03-2025
- Dividend Yield
- OBIO N/A
- SLND N/A
- EPS Growth
- OBIO N/A
- SLND N/A
- EPS
- OBIO N/A
- SLND N/A
- Revenue
- OBIO $2,647,000.00
- SLND $1,029,117,999.00
- Revenue This Year
- OBIO $22.61
- SLND N/A
- Revenue Next Year
- OBIO $16.64
- SLND $6.18
- P/E Ratio
- OBIO N/A
- SLND N/A
- Revenue Growth
- OBIO N/A
- SLND N/A
- 52 Week Low
- OBIO $3.96
- SLND $1.85
- 52 Week High
- OBIO $8.87
- SLND $6.16
- Technical
- Relative Strength Index (RSI)
- OBIO 38.59
- SLND 49.31
- Support Level
- OBIO $5.20
- SLND $3.03
- Resistance Level
- OBIO $5.98
- SLND $3.33
- Average True Range (ATR)
- OBIO 0.42
- SLND 0.15
- MACD
- OBIO -0.07
- SLND 0.02
- Stochastic Oscillator
- OBIO 2.70
- SLND 68.68
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.